Cargando…
Randomised clinical trial: effect of low-FODMAP rye bread versus regular rye bread on the intestinal microbiota of irritable bowel syndrome patients: association with individual symptom variation
BACKGROUND: A low intake of Fermentable, Oligo-, Di-, Mono-saccharides and Polyols (FODMAPs) is effective in the symptom control of irritable bowel syndrome (IBS) patients but may exert negative effects on the intestinal microbiota. The microbial effects of increasing regular or non-FODMAP fibre sou...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050854/ https://www.ncbi.nlm.nih.gov/pubmed/32153925 http://dx.doi.org/10.1186/s40795-019-0278-7 |
_version_ | 1783502672297459712 |
---|---|
author | Laatikainen, Reijo Jalanka, Jonna Loponen, Jussi Hongisto, Sanna-Maria Hillilä, Markku Koskenpato, Jari Korpela, Riitta Salonen, Anne |
author_facet | Laatikainen, Reijo Jalanka, Jonna Loponen, Jussi Hongisto, Sanna-Maria Hillilä, Markku Koskenpato, Jari Korpela, Riitta Salonen, Anne |
author_sort | Laatikainen, Reijo |
collection | PubMed |
description | BACKGROUND: A low intake of Fermentable, Oligo-, Di-, Mono-saccharides and Polyols (FODMAPs) is effective in the symptom control of irritable bowel syndrome (IBS) patients but may exert negative effects on the intestinal microbiota. The microbial effects of increasing regular or non-FODMAP fibre sources are largely unknown. Furthermore, it is not known if the baseline microbiota composition is associated with individual symptom control during the consumption of different rye products in IBS patients. Our objective was to evaluate whether increased consumption of low-FODMAP rye bread or regular rye bread for 4 weeks would alter the intestinal microbiota composition of IBS patients following their habitual diet, and whether these changes associate to symptoms and/or the baseline microbiota. METHODS: The study was conducted as a randomized double blind controlled cross-over study (n = 50). Microbiota was analysed by 16S rRNA gene sequencing and associated with gastrointestinal symptoms. Both microbial changes and their associations to symptoms were secondary outcomes. RESULTS: The consumption of the test breads did not alter microbiota diversity. Compared to baseline, consumption of the low FODMAP rye bread decreased the abundance of Bacteroides, Flavonifractor, Holdemania, Parasutterella and Klebsiella and showed a trend towards increased bifidobacteria, whereas the regular rye bread decreased the abundance of Flavonifractor. When comparing between the two test breads, Klebsiella was decreased after low-FODMAP rye bread intake. Patients whose symptoms decreased during the low-FODMAP rye bread displayed more Blautia and less Barnesiella at baseline. CONCLUSIONS: Consumption of low-FODMAP rye bread had modest, potentially beneficial effects on patients’ microbiota while increasing their intake of fibre substantially. The baseline microbiota composition was associated with the variable degrees of symptom relief experienced by the patients. Consumption of a low-FODMAP rye bread might be one way to increase dietary fibre intake and improve the mild dysbiosis often observed among patients with IBS. TRIAL REGISTRATION: ClinicalTrials.gov: NCT02161120. Retrospectively registered 11 June 2014. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40795-019-0278-7) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7050854 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-70508542020-03-09 Randomised clinical trial: effect of low-FODMAP rye bread versus regular rye bread on the intestinal microbiota of irritable bowel syndrome patients: association with individual symptom variation Laatikainen, Reijo Jalanka, Jonna Loponen, Jussi Hongisto, Sanna-Maria Hillilä, Markku Koskenpato, Jari Korpela, Riitta Salonen, Anne BMC Nutr Research Article BACKGROUND: A low intake of Fermentable, Oligo-, Di-, Mono-saccharides and Polyols (FODMAPs) is effective in the symptom control of irritable bowel syndrome (IBS) patients but may exert negative effects on the intestinal microbiota. The microbial effects of increasing regular or non-FODMAP fibre sources are largely unknown. Furthermore, it is not known if the baseline microbiota composition is associated with individual symptom control during the consumption of different rye products in IBS patients. Our objective was to evaluate whether increased consumption of low-FODMAP rye bread or regular rye bread for 4 weeks would alter the intestinal microbiota composition of IBS patients following their habitual diet, and whether these changes associate to symptoms and/or the baseline microbiota. METHODS: The study was conducted as a randomized double blind controlled cross-over study (n = 50). Microbiota was analysed by 16S rRNA gene sequencing and associated with gastrointestinal symptoms. Both microbial changes and their associations to symptoms were secondary outcomes. RESULTS: The consumption of the test breads did not alter microbiota diversity. Compared to baseline, consumption of the low FODMAP rye bread decreased the abundance of Bacteroides, Flavonifractor, Holdemania, Parasutterella and Klebsiella and showed a trend towards increased bifidobacteria, whereas the regular rye bread decreased the abundance of Flavonifractor. When comparing between the two test breads, Klebsiella was decreased after low-FODMAP rye bread intake. Patients whose symptoms decreased during the low-FODMAP rye bread displayed more Blautia and less Barnesiella at baseline. CONCLUSIONS: Consumption of low-FODMAP rye bread had modest, potentially beneficial effects on patients’ microbiota while increasing their intake of fibre substantially. The baseline microbiota composition was associated with the variable degrees of symptom relief experienced by the patients. Consumption of a low-FODMAP rye bread might be one way to increase dietary fibre intake and improve the mild dysbiosis often observed among patients with IBS. TRIAL REGISTRATION: ClinicalTrials.gov: NCT02161120. Retrospectively registered 11 June 2014. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40795-019-0278-7) contains supplementary material, which is available to authorized users. BioMed Central 2019-03-06 /pmc/articles/PMC7050854/ /pubmed/32153925 http://dx.doi.org/10.1186/s40795-019-0278-7 Text en © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Laatikainen, Reijo Jalanka, Jonna Loponen, Jussi Hongisto, Sanna-Maria Hillilä, Markku Koskenpato, Jari Korpela, Riitta Salonen, Anne Randomised clinical trial: effect of low-FODMAP rye bread versus regular rye bread on the intestinal microbiota of irritable bowel syndrome patients: association with individual symptom variation |
title | Randomised clinical trial: effect of low-FODMAP rye bread versus regular rye bread on the intestinal microbiota of irritable bowel syndrome patients: association with individual symptom variation |
title_full | Randomised clinical trial: effect of low-FODMAP rye bread versus regular rye bread on the intestinal microbiota of irritable bowel syndrome patients: association with individual symptom variation |
title_fullStr | Randomised clinical trial: effect of low-FODMAP rye bread versus regular rye bread on the intestinal microbiota of irritable bowel syndrome patients: association with individual symptom variation |
title_full_unstemmed | Randomised clinical trial: effect of low-FODMAP rye bread versus regular rye bread on the intestinal microbiota of irritable bowel syndrome patients: association with individual symptom variation |
title_short | Randomised clinical trial: effect of low-FODMAP rye bread versus regular rye bread on the intestinal microbiota of irritable bowel syndrome patients: association with individual symptom variation |
title_sort | randomised clinical trial: effect of low-fodmap rye bread versus regular rye bread on the intestinal microbiota of irritable bowel syndrome patients: association with individual symptom variation |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050854/ https://www.ncbi.nlm.nih.gov/pubmed/32153925 http://dx.doi.org/10.1186/s40795-019-0278-7 |
work_keys_str_mv | AT laatikainenreijo randomisedclinicaltrialeffectoflowfodmapryebreadversusregularryebreadontheintestinalmicrobiotaofirritablebowelsyndromepatientsassociationwithindividualsymptomvariation AT jalankajonna randomisedclinicaltrialeffectoflowfodmapryebreadversusregularryebreadontheintestinalmicrobiotaofirritablebowelsyndromepatientsassociationwithindividualsymptomvariation AT loponenjussi randomisedclinicaltrialeffectoflowfodmapryebreadversusregularryebreadontheintestinalmicrobiotaofirritablebowelsyndromepatientsassociationwithindividualsymptomvariation AT hongistosannamaria randomisedclinicaltrialeffectoflowfodmapryebreadversusregularryebreadontheintestinalmicrobiotaofirritablebowelsyndromepatientsassociationwithindividualsymptomvariation AT hillilamarkku randomisedclinicaltrialeffectoflowfodmapryebreadversusregularryebreadontheintestinalmicrobiotaofirritablebowelsyndromepatientsassociationwithindividualsymptomvariation AT koskenpatojari randomisedclinicaltrialeffectoflowfodmapryebreadversusregularryebreadontheintestinalmicrobiotaofirritablebowelsyndromepatientsassociationwithindividualsymptomvariation AT korpelariitta randomisedclinicaltrialeffectoflowfodmapryebreadversusregularryebreadontheintestinalmicrobiotaofirritablebowelsyndromepatientsassociationwithindividualsymptomvariation AT salonenanne randomisedclinicaltrialeffectoflowfodmapryebreadversusregularryebreadontheintestinalmicrobiotaofirritablebowelsyndromepatientsassociationwithindividualsymptomvariation |